Association between transforming growth factor-β1 and left ventricular mass and diameter in hypertensive patients

Journal of the American Society of Hypertension

Volumn 4, Issue 3, 2010, Pages 135-141

  Almendral, Jesus L ^a,b   Shick, Vladislav ^a,b   Rosendorff, Clive ^a,b   Atlas, Steven A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Echocardiography; growth factors; left ventricular hypertrophy; renin angiotensin aldosterone system

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RENIN; TRANSFORMING GROWTH FACTOR BETA1; BIOLOGICAL MARKER;

ADULT; AGE DISTRIBUTION; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GEOMETRY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; TREATMENT DURATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BLOOD; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FOLLOW UP; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS;

BIOLOGICAL MARKERS; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROGNOSIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77954691071     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2010.02.007     Document Type: Article

References (30)

1. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham study N Engl J Med 322 1990 1561 1566 (Pubitemid 20176696)
2. M.S. Lauer, K.M. Anderson, and D. Levy Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: The Framingham Heart study J Am Coll Cardiol 18 1991 1287 1294
3. F.R. Bauwens, D.A. Duprez, M.L. De Buyzere, T.L. De Backer, J.M. Kaufman, and J. Van Hoecke Influence of the arterial blood pressure and non-hemodynamic factors on left ventricular hypertrophy in moderate essential hypertension Am J Cardiol 68 1991 925 929
4. E. Boley, T.G. Pickering, G.D. James, G. de Simone, M.J. Roman, and R.B. Devereux Relations of ambulatory blood pressure level and variability to left ventricular and arterial function and to left ventricular mass in normotensive and hypertensive adults Blood Press Monit 2 1997 323 331
5. T. Yamazaki, I. Komuro, and Y. Yazaki Role of the renin-angiotensin system in cardiac hypertrophy Am J Cardiol 83 1999 H53 H57
6. J.M. Schnee, and W.A. Hsueh Angiotensin II, adhesion, and cardiac fibrosis Cardiovasc Res 46 2000 264 268
7. W. Shorb, G.W. Booz, D.E. Dostal, K.M. Conrad, K.C. Chang, and K.M. Baker Angiotensin II is mitogenic in neonatal rat cardiac fibroblast Circ Res 72 1993 1245 1254
8. 1 and angiotensin networking in cardiac remodeling Cardiovasc Res 63 2002 423 432
9. 1 expression in rat ventricular myocytes J Clin Invest 94 1994 1470 1476
10. H. Tomita, K. Egashira, Y. Ohara, M. Takemoto, M. Koyanagi, and M. Katoh Early induction of transforming growth factor-β via angiotensin II type 1 receptors contribute to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats Hypertension 32 1998 273 279
11. F.K. Villarreal, and W.H. Dillmann Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin and collagen Am J Physiol 262 1992 H1861 H1866
12. S. Hein, E. Arnon, S. Kostin, M. Schonburg, A. Elsasser, and V. Polyakova Progression from compensated hypertrophy to failure in the pressure-overloaded human heart Circulation 107 2003 984 991
13. C. Laviades, N. Varo, and J. Diez Transforming growth factor-beta in hypertensives with cardiorenal damage Hypertension 36 2000 517 522
14. R.B. Devereux, D.R. Alosnso, E.M. Lutas, G.J. Gottlieb, E. Campo, and I. Sachs Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458
15. J. Fielitz, S. Hein, V. Mitrovic, R. Pregla, H.R. Zurbugg, and C. Warnecke Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease J Am Coll Cardiol 37 2001 1443 1449
16. M.O. Boluyt, L. O'Neill, A.L. Meredith, O.H.L. Bing, W.W. Brooks, and C.H. Conrad Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure Circ Res 75 1994 23 32
17. R.E. Schmeider, H.P. Schobel, and F.H. Messerli Central blood volume: a determinant of early cardiac adaptation in arterial hypertension? J Am Coll Cardiol 26 1995 1692 1698
18. R.P. Dai, S.T. Dheen, B.P. He, and S.S.W. Tay Differential expression of cytokines in the heart in response to sustained volume overload Eur J Heart Fail 6 2004 693 703
19. 1 expression in cardiomyocytes Mol Cell Biochem 236 2002 147 153
20. J.E.J. Schultz, S.A. Witt, B.J. Glascock, M.L. Nieman, P.J. Reiser, and S.L. Nix TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II J Clin Invest 109 2002 787 796
21. 3 in cardiomyocytes during pressure overload-induced hypertrophy J Moll Cell Cardiol 29 1997 2213 2224
22. F. Kuwahara, H. Kai, K. Tokuda, M. Kai, A. Takeshita, and K. Egashira Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats Circulation 106 2002 130 135
23. W.A. Border, and N.A. Noble Transforming growth factor-β in tissue fibrosis N Engl J Med 331 1994 1286 1292
24. G.C. Blobe, W.P. Scheimann, and H.F. Lodish Role of transforming growth factor β in human disease N Engl J Med 324 2000 1350 1358
25. 1 in human blood samples J Immunol Methods 209 1997 203 206
26. 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage Proc Natl Acad Sci U S A 97 2000 3479 3484
27. K. Yasunari, K. Maeda, T. Watanabe, M. Nakamura, J. Yoshikawa, and A. Asada Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy J Am Coll Cardiol 43 2004 2116 2123
28. A.P. Schroeder, I. Sihm, B. Mørn, K. Thygesen, E.B. Pedersen, and O. Lederballe Influence of humoral and neurohormonal factors on cardiovascular hypertrophy in untreated essential hypertensives Am J Hypertens 9 1996 207 215
29. M.J. Roman, T.G. Pickering, R. Pini, J.E. Schwartz, and R.B. Devereux Prevalence and determinants of cardiac and vascular hypertrophy in hypertension Hypertension 26 1995 369 373
30. M.H. Olsen, K. Wachtell, K.L. Hermann, E. Frandsen, H. Dige-Petersen, and J. Rokkedal Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy Am Heart J 144 2002 530 537